MedPath

Invibio Ltd

Invibio Ltd logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of Total Knee Replacement Surgery for the Treatment of Knee Arthritis

Recruiting
Conditions
Complete Questionnaires Following TKR Surgery
First Posted Date
2024-09-05
Last Posted Date
2024-12-16
Lead Sponsor
Invibio Ltd
Target Recruit Count
150
Registration Number
NCT06585267
Locations
🇬🇧

Chapel Allerton Hospital, Leeds, United Kingdom

A Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus

Recruiting
Conditions
Hallux Rigidus
First Posted Date
2023-01-20
Last Posted Date
2025-04-30
Lead Sponsor
Invibio Ltd
Target Recruit Count
40
Registration Number
NCT05692687
Locations
🇺🇸

South Florida Foot and Ankle Center, Lake Worth, Florida, United States

🇺🇸

University of Kansas Medical Centre, Kansas City, Kansas, United States

🇺🇸

Mississippi Sports Medicine and Orthopedic Center,, Jackson, Mississippi, United States

Study to Evaluate the Clinical and Radiographic Outcomes of the BEE® HA Cage for Anterior Cervical Discectomy and Fusion

Recruiting
Conditions
Cervical Disc Degeneration
First Posted Date
2022-11-30
Last Posted Date
2025-04-30
Lead Sponsor
Invibio Ltd
Target Recruit Count
51
Registration Number
NCT05631392
Locations
🇩🇪

Bg Klinikum Bergmannstrost Halle, Halle, Germany

Qualitative Interviews With Healthcare Professionals

Completed
Conditions
Total Knee Replacement
First Posted Date
2022-10-27
Last Posted Date
2022-11-09
Lead Sponsor
Invibio Ltd
Target Recruit Count
6
Registration Number
NCT05597046
Locations
🇺🇸

AAKHS conference, Dallas, Dallas, Texas, United States

A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced.

Not Applicable
Recruiting
Conditions
Spondylolisthesis
Retrolisthesis
Degenerative Disc Disease
First Posted Date
2020-06-04
Last Posted Date
2025-04-30
Lead Sponsor
Invibio Ltd
Target Recruit Count
30
Registration Number
NCT04416321
Locations
🇺🇸

Neurosurgical Associates of Lancaster, Lancaster, Pennsylvania, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath